Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Particle therapy in head and neck cancer—expanding therapeutic options

Particle therapy in head and neck cancer—expanding therapeutic options Summary The management of head and neck tumors is challenging and requires a multidisciplinary approach. Besides the common histology of squamous cell cancer, other histologies like adenoid cystic carcinoma, mucosal melanoma, and adenocarcinoma are often present. These tumors are radioresistant and need high radiation doses. Photon beam therapy is often limited by the normal tissue tolerance, and particle therapy using protons or carbon ions is a valuable treatment option. Due to their dosimetric advantages, protons enable deposition of high tumor doses, while optimally sparing the surrounding tissue. Carbon ions offer the additional advantage of a higher linear energy transfer (LET) which results in a higher biological effectiveness of tumor cell damage. Therefore, while protons can also be used in sterilizing microscopic disease, carbon ions should be considered in large macroscopic disease, where a significant tumor burden has to be managed. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Particle therapy in head and neck cancer—expanding therapeutic options

Georg, Petra
memo - Magazine of European Medical Oncology , Volume 13 (4): 6 – Dec 1, 2020
Download PDF
6 pages

Loading next page...
 
/lp/springer-journals/particle-therapy-in-head-and-neck-cancer-expanding-therapeutic-options-y0c4E92Sv0
Publisher
Springer Journals
Copyright
2020 Springer-Verlag GmbH Austria, part of Springer Nature
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-020-00623-y
Publisher site
See Article on Publisher Site

Abstract

Summary The management of head and neck tumors is challenging and requires a multidisciplinary approach. Besides the common histology of squamous cell cancer, other histologies like adenoid cystic carcinoma, mucosal melanoma, and adenocarcinoma are often present. These tumors are radioresistant and need high radiation doses. Photon beam therapy is often limited by the normal tissue tolerance, and particle therapy using protons or carbon ions is a valuable treatment option. Due to their dosimetric advantages, protons enable deposition of high tumor doses, while optimally sparing the surrounding tissue. Carbon ions offer the additional advantage of a higher linear energy transfer (LET) which results in a higher biological effectiveness of tumor cell damage. Therefore, while protons can also be used in sterilizing microscopic disease, carbon ions should be considered in large macroscopic disease, where a significant tumor burden has to be managed.

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: Dec 1, 2020

Keywords: oncology; medicine/public health, general

References

  • Proton therapy for head and neck cancer: expanding the therapeutic window
    JE Leeman, PB Romesser, Y Zhou, S McBride, N Riaz, E Sherman
  • Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer
    SG Park, YC Ahn, D Oh, JM Noh, SG Ju, D Kwon
  • Efficacy and toxicity of proton with photon radiation for locally advanced nasopharyngeal carcinoma
    A Beddok, L Feuvret, G Noel, S Bolle, M Deberne, H Mammar
  • Bimodal radiotherapy with active raster-scanning carbon ion radiotherapy and intensity-modulated radiotherapy in high-risk nasopharyngeal carcinoma results in excellent local control
    S Akbaba, T Held, K Lang, T Forster, P Federspil, K Herfarth
  • A multi-institutional retrospective study of carbon-ion radiotherapy for non-squamous cell malignant tumors of the nasopharynx: Subanalysis of Japan Carbon-Ion Radiation Oncology Study Group study 1402 HN
    T Abe, T Ohno, M Koto, Y Demizu, H Suefuji, H Tsuji
  • Proton radiation for treatment of cancer of the oropharynx: Early experience at Loma Linda University Medical Center using a concomitant boost technique
    JD Slater, LT Yonemoto, DW Mantik, DA Bush, W Preston, RI Grove
  • Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy
    AF Bagley, R Ye, AS Garden, GB Gunn, DI Rosenthal, CD Fuller
  • Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis
    SH Patel, Z Wang, WW Wong, MH Murad, CR Buckey, K Mohammed
  • Long-term outcomes after proton beam therapy for sinonasal squamous cell carcinoma
    AL Russo, JA Adams, EA Weyman, PM Busse, SI Goldberg, M Varvares
  • Outcomes of sinonasal cancer treated with proton therapy
    R Dagan, C Bryant, Z Li, D Yeung, J Justice, P Dzieglewiski
  • High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years’ experience with raster-scanned carbon ion therapy
    AD Jensen, M Poulakis, AV Nikoghosyan, T Welzel, M Uhl, PA Federspil
  • Treatment outcome of 227 patients with sinonasal adenoid cystic carcinoma (ACC) after intensity modulated radiotherapy and active raster-scanning carbon ion boost: A 10-year single-center experience
    S Akbaba, D Ahmed, A Mock, T Held, S Bahadir, K Lang
  • The phase 1/2 ACCEPT trial: concurrent cetuximab and intensity modulated radiation therapy with carbon Ion boost for adenoid cystic carcinoma of the head and neck
    S Adeberg, S Akbaba, K Lang, T Held, V Verma, A Nikoghosyan
  • Definitive carbon-ion radiation therapy for locally advanced sinonasal malignant tumors: Subgroup analysis of a multicenter study by the Japan Carbon-Ion Radiation Oncology Study group (J-CROS)
    M Koto, Y Demizu, J-I Saitoh, H Suefuji, H Tsuji, T Okimoto
  • Multicenter study of carbon-ion radiation therapy for adenoid cystic carcinoma of the head and neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study group (J-CROS) study (1402 HN)
    NS Sulaiman, Y Demizu, M Koto, J-I Saitoh, H Suefuji, H Tsuji
  • Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation
    PB Romesser, O Cahlon, E Scher, Y Zhou, SL Berry, A Rybkin
  • COSMIC: a regimen of intensity modulated radiation therapy plus dose-escalated, raster-scanned carbon Ion boost for malignant salivary gland tumors: results of the prospective phase 2 trial
    AD Jensen, AV Nikoghosyan, K Lossner, T Haberer, O Jäkel, MW Münter
  • Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
    AD Jensen, M Poulakis, V Vanoni, M Uhl, N Chaudhri, PA Federspil
  • Intensity Modulated Radiotherapy (IMRT) with carbon Ion boost in the multimodal treatment of salivary duct carcinoma
    S Adeberg, P Windisch, F Ehret, M Baur, S Akbaba, T Held
  • Multi-institutional retrospective study of mucoepidermoid carcinoma treated with carbon-ion radiotherapy
    K Shirai, M Koto, Y Demizu, H Suefuji, T Ohno, H Tsuji
  • Proton therapy for head and neck cancers
    P Blanchard, GB Gunn, A Lin, RL Foote, NY Lee, SJ Frank
  • Carbon ion reirradiation for recurrent head and neck cancer: a single-institutional experience
    T Held, P Windisch, S Akbaba, K Lang, R Shafie, D Bernhardt
  • Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy
    AD Jensen, M Poulakis, AV Nikoghosyan, N Chaudhri, M Uhl, MW Münter
  • Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results
    J Hu, C Bao, J Gao, X Guan, W Hu, J Yang